Carmine Therapeutics, headquartered in Cambridge MA, is pioneering a new class of non-viral gene therapies based on red blood cell extracellular vesicles, combined with proprietary payloads.

Biotechnology

Carmine Therapeutics

Carmine Therapeutics' headquarters in Cambridge, MA, United States

Tenzin Gocha

Xq Lin

Jianzhu Chen

Minh Le

Jiahai Shi

Harvey Lodish

Mark Kay

The Scientific Advisory Team at Carmine Therapeutics provides expert guidance on the development and optimization of non-viral gene therapies using red blood cell extracellular vesicles. They leverage their extensive scientific backgrounds to shape strategic research initiatives, assess emerging technologies, and ensure alignment with industry standards, thereby enhancing the company's innovative therapeutic approaches.

Scientific Advisory Team

The Leadership Team at Carmine Therapeutics drives the strategic vision and direction of the company, leveraging their extensive expertise in gene therapy and biotechnology. They oversee research and development initiatives, foster partnerships, and guide the execution of innovative projects to advance the next generation of non-viral gene therapies, ensuring the alignment of scientific and business goals.

Carmine Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Carmine Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Offices

Related companies